ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...
Posted by : Pr. Franck BONNETAIN
Journal name : Expert Review of Anticancer Therapy
ABSTRACTIntroduction: Intermediate endpoints are often used as primary endpoints instead of overall survival (OS) in...
Posted by : Pr. Franck BONNETAIN
Journal name : Expert Review of Anticancer Therapy
Background:To assess the efficacy of a patient educational program built according to guidelines that aims at reducing...
Posted by : Pr. Franck BONNETAIN
Journal name : British Journal of Cancer
Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...
Posted by : Mme. Aurélia MEURISSE, Pr. Franck BONNETAIN
Journal name : Lancet Gastroenterology Hepatology
BackgroundEven if a large majority of out-of-hospital cardiac arrest (OHCA) survivors appear to have a good neurological...
Posted by : Pr. Franck BONNETAIN
Journal name : Resuscitation
The measurement of the quality of life in terms of health of people undergoing treatment for cancer is developing. Th is...
Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH,
Journal name : La revue de l'infirmière
SummaryData in the literature regarding the care pathway of pancreatic cancer patients are limited. The objective of the...
Posted by : Pr. Franck BONNETAIN
Journal name : Bulletin du Cancer
Background: Medical progress and the lifestyle modification have prolonged life expectancy, despite the development of...
Posted by : , Pr. Franck BONNETAIN
Journal name : Trials
AbstractBackground:Frailty is highly prevalent in elderly people. While significant progress has been made to...
Posted by : Dr. Dewi VERNEREY, Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Journal name : BMC Geriatrics
AbstractBackground:Pancreatic adenocarcinoma (PDAC) incidence is increasing worldwide. Several studies have shown...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : BMC Cancer
Measures of health-related quality of life (HRQOL) and other patient-reported outcomes generate important data in cancer...
Posted by : Pr. Franck BONNETAIN
Journal name : Lancet Oncology
Docetaxel, cisplatin, and 5-fluorouracil (DCF) significantly improved overall survival in metastatic gastroesophageal...
Posted by : Pr. Franck BONNETAIN, Dr. Sophie PAGET-BAILLY
Journal name : Cancer Medecine
Background:The management of locally advanced pancreatic cancer (LAPC) patients remains controversial. Better...
Posted by : Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Journal name : British Journal of Cancer
In first-line metastatic colorectal cancer (mCRC), baseline prognostic factors allowing death risk and treatment...
Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN
Journal name : International Journal of Cancer
Our aim was to review the studies which assessed potential surrogate endpoints for overall survival (OS) in breast...
Posted by : Pr. Franck BONNETAIN,
Journal name : Breast
In the Intergroupe Francophone de Cancérologie Thoracique 0501 trial the carboplatinpaclitaxel chemotherapy increased...
Posted by : Pr. Franck BONNETAIN
Journal name : European Respiratory Journal
Background: Even though the perioperative chemotherapy improves the overall survival (OS) compared to surgery alone in...
Posted by : Dr. Sophie PAGET-BAILLY, , Pr. Franck BONNETAIN
Journal name : European Journal of Surgical Oncology
AbstractGlioblastoma is the most common malignant brain tumor in adults. Baselinehealth-relatedquality of life (HRQoL)...
Posted by : , Dr. Dewi VERNEREY, , Pr. Franck BONNETAIN
Journal name : Cancer Medicine
PurposeWe previously showed that a sequential chemotherapy with dose-dense oxaliplatin (FOLFOX7)and irinotecan (FOLFIRI;...
Posted by : Pr. Franck BONNETAIN
Journal name : PLOS ONE
OBJECTIVES: The objective of this study was to explore the association between health-related quality of life (HRQoL)...
Posted by : , Pr. Franck BONNETAIN
Journal name : BMJ Open
OBJECTIVES: We conducted a prospective study approved by the local ethics committee to determine the impact of a...
Posted by : Pr. Franck BONNETAIN
Journal name : Annales pharmaceutiques françaises